Italy’s Garofalo Health Care’s (GHC) first results since its IPO at the end of last year, have been received well by the market. The group reported a 16% jump in adjusted operating EBITDA (neutralising the IPO costs) of €29.1 million (US$33.1 million) on revenues up 13.4% to €154.9 million. “The significantly improving 2018 results are…
©2023 All rights reserved LaingBuisson 
 first results since its IPO at the end of last year, have been received well by the market.){kind=link}